EP2697218
Aðferð til að framleiða efnasambönd sem eru gagnleg sem SGLT2 hemlar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.4.2012EP published:
25.5.2016EP application number:
12715362.5
EP translation filed:
8.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
11.4.2032Expiry date:
11.4.2026Next due date:
30.4.2026
Title:
PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT2
Timeline
Today
12.4.2012EP application
25.5.2016EP Publication
8.8.2016Translation submitted
15.9.2016Registration published
11.4.2026Expires
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340, Beerse, BE
Inventor
Name:
HOUPIS, Ioannis, NicolaosAddress:
Beerse, BE
Name:
LEMAIRE, Sebastien, François, EmmanuelAddress:
Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161474936 PDate:
13.4.2011Country:
US
Classification
Categories:
C07D 409/10, C07D 409/14
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.3.2017
Expires: 11.4.2018
Payer: Árnason Faktor
Number: 7
Paid: 5.3.2018
Expires: 11.4.2019
Payer: Árnason Faktor
Number: 8
Paid: 8.3.2019
Expires: 11.4.2020
Payer: Árnason Faktor
Number: 9
Paid: 10.3.2020
Expires: 11.4.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.3.2021
Expires: 11.4.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.3.2022
Expires: 11.4.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 8.3.2023
Expires: 11.4.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.3.2024
Expires: 11.4.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 14.3.2025
Expires: 11.4.2026
Payer: Árnason Faktor ehf.